Cargando…

Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study

BACKGROUND: Oxaliplatin is a third-generation platinum compound that has efficacy against colorectal cancer. Hypersensitivity reactions during oxaliplatin infusion are a key problem during its use, with the varying incidences and deficiencies of clearly identified risk factors. OBJECTIVE: To determi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palapinyo, Sirinoot, Klaewsongkram, Jettanong, Sriuranpong, Virote, Areepium, Nutthada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296088/ https://www.ncbi.nlm.nih.gov/pubmed/35919789 http://dx.doi.org/10.18549/PharmPract.2022.2.2635

Ejemplares similares

Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions
por: Klaewsongkram, Jettanong, et al.
Publicado: (2020)

A multidisciplinary approach to verify and de-label of drug allergic histories in a university hospital in Thailand: a retrospective descriptive study
por: Palapinyo, Sirinoot, et al.
Publicado: (2023)

Effect of the ERCC1 (C118T) Polymorphism on Treatment Response in Advanced Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy
por: Kaewbubpa, Walennee, et al.
Publicado: (2016)

Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients
por: Charoenchokthavee, Wanaporn, et al.
Publicado: (2017)

Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
por: Charoenchokthavee, Wanaporn, et al.
Publicado: (2016)

555 Frequency, Characteristics and Outcome of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media
por: Kampitak, Thatchai, et al.
Publicado: (2012)

The Impact of Omitting 5-FU Bolus From mFOLFOX6 Chemotherapy Regimen on Hematological Adverse Events Among Patients With Metastatic Colorectal Cancer
por: Areepium, Nutthada, et al.
Publicado: (2023)

A Case of Sulfasalazine-Induced Hypersensitivity Syndrome Confirmed by Enzyme-Linked Immunospot Assay
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2013)

Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy
por: Treenert, Apatsara, et al.
Publicado: (2018)

Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients
por: Shen, Yuping, et al.
Publicado: (2018)

Hypersensitivity reactions related to oxaliplatin (OHP)
por: Brandi, G, et al.
Publicado: (2003)

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy
por: Liblab, Salisa, et al.
Publicado: (2020)

Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
por: Seki, Kyoko, et al.
Publicado: (2011)

The Differences and Similarities between Allergists and Non-Allergists for Penicillin Allergy Management
por: Suetrong, Nayot, et al.
Publicado: (2014)

Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy
por: Pongmaneratanakul, Skolchart, et al.
Publicado: (2017)

Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein
por: Triwatcharikorn, Jidapa, et al.
Publicado: (2022)

Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients
por: Zhu, Linhui, et al.
Publicado: (2021)

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review
por: Barbin, Francesca, et al.
Publicado: (2022)

Serum Lactate Dehydrogenase Levels as a Predictive Marker of Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
por: Seki, Kyoko, et al.
Publicado: (2014)

Ranitidine and the incidence of hypersensitivity reactions to paclitaxel: A retrospective cohort study
por: Haine, Anouk I., et al.
Publicado: (2022)

Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells
por: CHUNHACHA, PREEDAKORN, et al.
Publicado: (2013)

Hypersensitivity to oxaliplatin: clinical features and risk factors
por: Parel, Marie, et al.
Publicado: (2014)

Differentiating between Laryngopharyngeal Dysesthesia and Hypersensitivity Reactions to Oxaliplatin and Addressing Dyspnea: 2 Case Reports
por: Kawaguchi, Fumitaka, et al.
Publicado: (2023)

HLA-B(*)58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
por: Sukasem, Chonlaphat, et al.
Publicado: (2016)

Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
por: Pratoomwun, Jirawat, et al.
Publicado: (2021)

Acute respiratory failure secondary to eosinophilic pneumonia following influenza vaccination in an elderly man with chronic obstructive pulmonary disease
por: Pornsuriyasak, Prapaporn, et al.
Publicado: (2014)

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature
por: Bautista, Marnelli A, et al.
Publicado: (2010)

Incidence Rate of Hypersensitivity Reactions to Bee-Venom Acupuncture
por: Lee, Eun-Jung, et al.
Publicado: (2020)

Difficult to Control Asthma During COVID-19 Lockdown
por: Chantaphakul, Hiroshi, et al.
Publicado: (2022)

High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2017)

Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients
por: Teocharoen, Rattanawadee, et al.
Publicado: (2021)

Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis
por: Ngamphaiboon, Nuttapong, et al.
Publicado: (2021)

Chronic cough: an Asian perspective. Part 1: Epidemiology
por: Song, Woo-Jung, et al.
Publicado: (2015)

A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial
por: Yoshida, Yoichiro, et al.
Publicado: (2015)

Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Panpruk, Rawiphan, et al.
Publicado: (2021)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors
por: Descoeur, Juliette, et al.
Publicado: (2011)

Effects of Complementary and Alternative Medicine on Chemotherapy Delivery in Thai Patients
por: Rabiltossaporn, Chawanya, et al.
Publicado: (2021)

Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients
por: Chayangsu, Chawalit, et al.
Publicado: (2023)

The Incidence of Delayed-Type Hypersensitivity Reactions to Apples Among Patients Allergic to Birch Pollen
por: Wagner, Aneta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d27k0irgt5oduojtt09835dame